Skip to main content
. Author manuscript; available in PMC: 2025 Jul 31.
Published in final edited form as: Liver Transpl. 2024 Mar 13;30(8):848–861. doi: 10.1097/LVT.0000000000000362

Table 1:

Key challenges, disparities and opportunities in liver transplantation for alcohol-associated liver disease and their root causes

Challenges Root Cause(s) Examples
of
Opportunities
for
Future
Implementation
and
Research
Geographic variation in transplant rates for ALD Differences in regional availability and accessibility of transplant centers, donor organs, and addiction services Creating Centers of Excellence via Hub and Spoke or Colocated models
Testing hybrid telem edicine/in-person models of AUD care
Lower transplant rates for Black patients with ALD Barriers to referral and evaluation for transplant - lack of insurance, social support, and transportation, possible implicit/explicit bias Shifting payor policies, Medicaid expansion
Leveraging EHR to identify at-risk patients within health systems
Understanding patient-, provider-, and system-level barriers to engagement in AUD treatment
Lower transplant rates for women with ALD Higher mortality and dropout rates on the waitlist, possibly due to more advanced disease, lower MELD scores, and higher rates of infection and sepsis, possible implicit/explicit bias Increasing provider education and public education about evolving transplant practices
Leveraging EHR to identify at-risk patients within health systems
Lower transplant rates for older patients with ALD Age-related comorbidities, frailty, and reduced life expectancy
Lower post-transplant survival for patients with ALD Relapse to alcohol use, medication nonadherence, and psychosocial issues Multidisciplinary programs to reduce post-LT relapse
Optimal screening and monitoring strategies for return to alcohol use
Standardization of best practices and center resources for addiction support
Testing safety and comparative effectiveness of AUD pharmacotherapy in the transplant recipients